CMS Decides to Place MDx Test Codes Under Clinical Lab Fee Schedule | GenomeWeb

NEW YORK (GenomeWeb News) – In a final ruling, the Centers for Medicare & Medicaid Services has decided to reimburse the new molecular pathology claims codes published by the American Medical Association in its payment channel dedicated to laboratory tests.

However, for a minority of tests that require a doctor's interpretation, that portion will be accounted for via the payment pathway for physicians' services.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.

Arizona is planning to sue Theranos for "deceptive acts" and misrepresentations of its "capabilities and operation."

If confirmed as Department of Health and Human Services Secretary, Tom Price says he will divest himself of certain holdings, according to Stat News.

Oliver Smithies, who won the Nobel Prize in 2007, has died, the New York Times reports.